Status:
COMPLETED
Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis
Lead Sponsor:
Yesfa Sebnem Ozbay
Conditions:
Arthritis, Juvenile Rheumatoid
Medication Adherence
Eligibility:
All Genders
Up to 18 years
Brief Summary
The goal of this observational study is to learn about the drug compliance of patients with juvenile idiopathic arthritis and, to figure our factors that affect the compliance. The main questions it ...
Eligibility Criteria
Inclusion
- Being followed up with the diagnosis of Juvenile Idiopathic Artritis (JIA) from the pediatric rheumatology outpatient clinic of Istanbul University, Istanbul Faculty of Medicine
Exclusion
- Refusal of patients or their parents to participate in the study
- Although the patient is followed up with the diagnosis of JIA, not using medication
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT06000566
Start Date
December 1 2022
End Date
March 1 2024
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University
Istanbul, Fatih, Turkey (Türkiye)